<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="889">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04330690</url>
  </required_header>
  <id_info>
    <org_study_id>2114</org_study_id>
    <nct_id>NCT04330690</nct_id>
  </id_info>
  <brief_title>Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial</brief_title>
  <acronym>CATCO</acronym>
  <official_title>A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Apotex Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an adaptive, randomized, open-label, controlled clinical trial, in
      collaboration with countries around the world through the World Health Organization.

      Subjects will be randomized to receive either standard-of-care products or the study
      medication plus standard of care, while being hospitalized for COVID-19.

      Participants will be randomized to one of the following groups:

        1. Lopinavir/ritonavir 400mg/100mg PO BID for 14 day plus optimized supportive care, OR

        2. Hydroxychloroquine 800mg BID for 1 day then 400mg BID for 10 days plus optimized
           supportive care, OR

        3. Remdesivir 200mg IV on day 1, followed by 100 mg IV daily infusion for 9 days plus
           optimized supportive care, OR

        4. Optimized support care all or until discharge from hospital, whichever occurs first
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is an adaptive, randomized, open-label, controlled clinical trial, in
      collaboration with countries around the world through the World Health Organization.

      Subjects will be randomized to receive either standard-of-care products or the study
      medication plus standard of care, while being hospitalized for COVID-19.

      Participants will be randomized to one of the following groups:

        1. Lopinavir/ritonavir 400mg/100mg PO BID for 14 day plus optimized supportive care, OR

        2. Hydroxychloroquine 800mg BID for 1 day then 400mg BID for 10 days plus optimized
           supportive care, OR

        3. Remdesivir 200mg IV on day 1, followed by 100 mg IV daily infusion for 9 days plus
           optimized supportive care, OR

        4. Optimized support care all or until discharge from hospital, whichever occurs first

      Subjects will be assessed daily while hospitalized, including Oropharyngeal (OP) /
      Nasopharyngeal (NP) swabbing at baseline and on days post enrolment 3, 5, 8, 11, 15 and 29
      (if still hospitalized, exploratory outcome). Discharged subjects will be telephoned at Days
      11, 15 29, and 60. Hospitalized subjects will require blood sampling on days 1, 5 and 11.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 18, 2020</start_date>
  <completion_date type="Anticipated">May 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 18, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>4-arms in a 1:1:1:1 ratio randomization to either the control arm, consisting of standard supportive care treatment for COVID-19, or the investigational product, lopinavir/ritonavir plus standard supportive care; hydroxychloroquine plus standard supportive care; and remdesivir plus standard supportive care
This study is intended to allow for multiple adaptations, including: i) the primary endpoint at the first interim analysis, based on performance characteristics, both in its characteristics and its timepoint, with adapted sample size calculations performed for the new primary endpoints; ii) Intervention arm, with emerging data from both internal and external to the trial, with arms being dropped or added based on pre-specified stopping rules in conjunction with the DSMB.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Endpoint assessment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of Interventions as assessed by all-cause mortality</measure>
    <time_frame>29 days</time_frame>
    <description>All-cause mortality, assessed at hospital discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to improvement of one category from admission</measure>
    <time_frame>up to 60 days</time_frame>
    <description>Measure with Ordinal Scale the time it takes for subject improvement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject clinical status</measure>
    <time_frame>up to 60 days</time_frame>
    <description>Subject clinical status at days 3, 5, 8, 11, 15, 29, 60 measured using the ordinal scale below:
The scale is as below 0: Uninfected, no viral RNA
Asymptomatic, viral RNA detected
Symptomatic, independent
Symptomatic, Assistance Needed
Hospitalized: no oxygen therapy
Hospitalized, on oxygen
Hospitalized, Oxygen by NIV or high-flow
Mechanical ventilation, p/f&gt;150 or s/f &gt;200
Mechanical ventilation, p/f&lt;150 or s/f&lt;200 OR vasopressors
mechanical ventilation, p/f&lt;150 AND vasopressors, dialysis, or ECMO
death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Subject clinical status</measure>
    <time_frame>up to 60 days</time_frame>
    <description>Mean change in the ranking from baseline to days 3, 5, 8, 11, 15, 29, 60 using the ordinal scale below:
The scale is as below 0: Uninfected, no viral RNA
Asymptomatic, viral RNA detected
Symptomatic, independent
Symptomatic, Assistance Needed
Hospitalized: no oxygen therapy
Hospitalized, on oxygen
Hospitalized, Oxygen by NIV or high-flow
Mechanical ventilation, p/f&gt;150 or s/f &gt;200
Mechanical ventilation, p/f&lt;150 or s/f&lt;200 OR vasopressors
mechanical ventilation, p/f&lt;150 AND vasopressors, dialysis, or ECMO
death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen free days</measure>
    <time_frame>up to 29 days</time_frame>
    <description>the number of oxygen free days experienced</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of oxygen use</measure>
    <time_frame>up to 29 days</time_frame>
    <description>if the subject required oxygen during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of oxygen use</measure>
    <time_frame>up to 29 days</time_frame>
    <description>if the subject required oxygen, for how long was it required</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of new mechanical ventilation</measure>
    <time_frame>up to 29 days</time_frame>
    <description>if the subject required mechanical ventilation during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>up to 29 days</time_frame>
    <description>if the subject required mechanical ventilation, for how long was it required</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>up to 29 days</time_frame>
    <description>the length of hospitalization required</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 60 days</time_frame>
    <description>Mortality rates calculated at day 15, 29, and 60.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Incidence of Grade 3 and 4 Adverse Events (AEs) and Serious Adverse Events (SAEs)</measure>
    <time_frame>up to 30 days after last dose of drug adminstration</time_frame>
    <description>The safety of the intervention will be evaluated during the trial period as compared to the control arm as assessed by the cumulative incidence of Grade 3 and 4 AEs and SAEs using the Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Paediatric Adverse Events, version 2.1 (July 2017).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to viral clearance of lopinavir/ritonavir as compared to the control arm</measure>
    <time_frame>up to 29 days</time_frame>
    <description>To evaluate the virologic efficacy of lopinavir/ritonavir, hydroxychloroquine, or remdesivir as compared to the control arm as assessed by the percent of subjects with SARS-CoV-2 detectable in OP sample at days 3, 5, 8, 11, 15, and 29</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">2900</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm will receive standard supportive care guidelines for COVID-19. This is expected the vary regionally and may change throughout the trial based on new and emerging data on best care guidelines for patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lopinavir/ritonavir plus standard supportive care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lopinavir/ritonavir will be administered 400 mg/100 mg orally for a 14-day course, or until discharge from hospital, whichever occurs first plus expected standard supportive care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hydroxychloroquine plus standard supportive care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydroxychloroquine 800mg BID for 1 day then 400mg BID for 10 days plus optimized supportive care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remdesivir plus standard supportive care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remdesivir 200mg IV on day 1, followed by 100 mg IV daily infusion for 9 days plus optimized supportive care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lopinavir/ritonavir</intervention_name>
    <description>Lopinavir/ritonavir will be administered 400 mg/100 mg orally for a 14-day course plus supportive care, or until discharge from hospital, whichever occurs first</description>
    <arm_group_label>lopinavir/ritonavir plus standard supportive care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>Hydroxychloroquine 800mg BID for 1 day then 400mg BID for 10 days plus optimized supportive care or until discharge from hospital, whichever occurs first</description>
    <arm_group_label>hydroxychloroquine plus standard supportive care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remdesivir</intervention_name>
    <description>Remdesivir 200mg IV on day 1, followed by 100 mg IV daily infusion for 9 days plus optimized supportive care or until discharge from hospital, whichever occurs first</description>
    <arm_group_label>Remdesivir plus standard supportive care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ≥ 18 years of age

          2. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other
             commercial or public health assay in any specimen prior to randomization.

          3. Hospitalized at a participating centre

        Exclusion Criteria:

          1. Anticipated transfer to another hospital, within 72 hours, which is not a study site

          2. Expected to not survive beyond 24 hours

          3. Known allergy to study medication or its components (non-medicinal ingredients)

          4. Receiving one of the study drugs at time of enrolment

          5. Known pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vaseeharan Sathiyamoorthy</last_name>
    <role>Study Director</role>
    <affiliation>World Health Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Srinivas Murthy, MD</last_name>
    <phone>(604) 875-2778</phone>
    <email>srinivas.murthy@cw.bc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gail Klein</last_name>
    <phone>416-480-5632</phone>
    <email>CATCO@sunnybrook.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peter Lougheed Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T1Y 6J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Tremblay, MD</last_name>
      <phone>(403) 210-3866</phone>
      <email>atrembla@ucalgary.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Tremblay, MD</last_name>
      <phone>(403) 210-3866</phone>
      <email>atrembla@ucalgary.ca</email>
    </contact>
    <contact_backup>
      <last_name>Curtis Dumonceaux</last_name>
      <email>cjdumonc@ucalgary.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rockyview General Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2V 1P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Tremblay, MD</last_name>
      <phone>(403) 210-3866</phone>
      <email>atrembla@ucalgary.ca</email>
    </contact>
    <contact_backup>
      <last_name>Lisette Machado</last_name>
      <email>lmachado@ucalgary.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>South Health Campus</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3M 1M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Tremblay, MD</last_name>
      <phone>(403) 210-3866</phone>
      <email>atrembla@ucalgary.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5K0L4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ameeta Singh, BMBS, MSc</last_name>
      <phone>(780) 342-2300</phone>
      <email>ameeta@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Meagan Dunn</last_name>
      <email>mkaye@ualberta.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Misericordia Community Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5R 4H5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Conar O'Neil, MD</last_name>
      <phone>(780) 735-9192</phone>
      <email>conar@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Matt Munan</last_name>
      <phone>7807352858</phone>
      <email>Matt.Munan@covenanthealth.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hopsital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelson Lee, MD</last_name>
      <phone>780-492-8547</phone>
      <email>laishunn@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Kimberly Robertson</last_name>
      <phone>780-407-6945</phone>
      <email>Kimberly.Robertson2@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Nelson Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grey Nuns Community Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6L 5X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holly Hoang, MD</last_name>
      <phone>(780) 735-7236</phone>
      <email>hlhoang@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Barchard</last_name>
      <email>Jennifer.barchard@covenanthealth.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lions Gate Hospital</name>
      <address>
        <city>North Vancouver</city>
        <state>British Columbia</state>
        <zip>V7L 2L7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Joshua Douglas, MD</last_name>
      <phone>(604) 988-3494</phone>
      <email>james.douglas@vch.ca</email>
    </contact>
    <contact_backup>
      <last_name>Valla Sahraei</last_name>
      <phone>604-988-3131</phone>
      <phone_ext>4934</phone_ext>
      <email>Valla.sahraei@vch.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Richmond Hospital</name>
      <address>
        <city>Richmond</city>
        <state>British Columbia</state>
        <zip>V6X 1A2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Grant, MD</last_name>
      <phone>(604) 875-5083</phone>
      <email>jennifer.grant@vch.ca</email>
    </contact>
    <contact_backup>
      <last_name>Gabriel Loh</last_name>
      <phone>604-244-5519</phone>
      <email>Gabriel.Loh@vch.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital, Vancouver Coastal Health, Univeristy of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Mah, MD</last_name>
      <phone>604 612-1477</phone>
      <email>allimah@mail.ubc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Laura Oliveira</last_name>
      <phone>604 875-4111</phone>
      <phone_ext>64164</phone_ext>
      <email>laura.oliveira@ubc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Allison Mah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natasha Press, MD</last_name>
      <phone>604-341-9605</phone>
      <email>npress@cfenet.ubc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Leslie Love</last_name>
      <phone>604 682-2344</phone>
      <phone_ext>64242</phone_ext>
      <email>llove@cheos.ubc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Natasha Press, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Island Health - Royal Jubilee Hospital</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R 1J8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Ovekim, MD</last_name>
      <phone>250-370-8261</phone>
      <email>daniel.ovakim@viha.ca</email>
    </contact>
    <contact_backup>
      <last_name>Fiona Auld</last_name>
      <phone>250-213-7778</phone>
      <email>fiona.auld@viha.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Ovekim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Island Health - Victoria General Hospital</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8Z 6R5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Ovekim, MD</last_name>
      <phone>250-370-8261</phone>
      <email>daniel.ovakim@viha.ca</email>
    </contact>
    <contact_backup>
      <last_name>Fiona Auld</last_name>
      <phone>250-213-7778</phone>
      <email>fiona.auld@viha.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Ovekim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Island Health - Nanaimo Regional General Hospital</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V9S 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Ovakim, MD</last_name>
      <phone>250-370-8261</phone>
      <email>daniel.ovakim@viha.ca</email>
    </contact>
    <contact_backup>
      <last_name>Fiona Auld</last_name>
      <phone>250-213-7778</phone>
      <email>fiona.auld@viha.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Boniface Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoav Keynan, MD</last_name>
      <phone>(204) 977-5681</phone>
      <email>yoav.keynan@umanitoba.ca</email>
    </contact>
    <contact_backup>
      <last_name>Gary Annable</last_name>
      <email>gary.annable@umanitoba.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Eastern Regional Health Authority</name>
      <address>
        <city>Saint John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Daley, Infectious Disease Physician</last_name>
      <phone>709-777-2089</phone>
      <email>Peter.Daley@easternhealth.ca</email>
    </contact>
    <contact_backup>
      <last_name>Laura Genge</last_name>
      <phone>709-777-6996</phone>
      <email>laura.genge@easternhealth.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Regional Health Centre</name>
      <address>
        <city>Barrie</city>
        <state>Ontario</state>
        <zip>L4M 6M2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giulio Didiodato, MD</last_name>
      <phone>705 728 9090</phone>
      <email>didiodatog@rvh.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Christine Di Marco</last_name>
      <phone>705-728-9090</phone>
      <phone_ext>43341</phone_ext>
      <email>dimarcoc@rvh.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>William Osler Health System - Brampton Civic Hospital</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6R 3J7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Binnie, MD</last_name>
      <phone>905-494-2120</phone>
      <phone_ext>33558</phone_ext>
      <email>Alexandra.Binnie@williamoslerhs.ca</email>
    </contact>
    <contact_backup>
      <last_name>Sergio Borgia</last_name>
      <email>sergio.borgia@williamoslerhs.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>William Osler Health System - Etobicoke General Hospital</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <zip>M9V 1R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Binnie</last_name>
      <phone>905-494-2120</phone>
      <phone_ext>33558</phone_ext>
      <email>Alexandra.Binnie@williamoslerhs.ca</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Havey</last_name>
      <email>thomas.havey@williamoslerhs.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erick Duan, MD FRCPC</last_name>
      <phone>905-522-1155</phone>
      <email>Erick.duan@medportal.ca</email>
    </contact>
    <contact_backup>
      <last_name>France Clarke</last_name>
      <phone>(905) 522-1155</phone>
      <phone_ext>33633</phone_ext>
      <email>clarkef@mcmaster.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Grand River Hospital</name>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <zip>N2G 1G3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Giilck, MD</last_name>
      <phone>(519) 749-4300</phone>
      <email>stephen.giilck@medportal.ca</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Krokoszynski</last_name>
      <phone>519-749-4370</phone>
      <phone_ext>2664</phone_ext>
      <email>Kristin.krokoszynski@grhosp.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St.Joseph's Health Care</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Silverman, FRCP, FACP, AA HIV Med</last_name>
      <phone>(519) 646-6100</phone>
      <phone_ext>61726</phone_ext>
      <email>Michael.Silverman@sjhc.london.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Seema Parvathy</last_name>
      <phone>519-646-6100</phone>
      <phone_ext>61726</phone_ext>
      <email>SeemaNair.Parvathy@sjhc.london.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Silverman, FRCP, FACP, AA HIV Med</last_name>
      <phone>(519) 646-6100</phone>
      <phone_ext>61726</phone_ext>
      <email>Michael.Silverman@sjhc.london.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Victoria Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Silverman, FRCP, FACP, AA HIV Med</last_name>
      <phone>(519) 646-6100</phone>
      <phone_ext>61726</phone_ext>
      <email>Michael.Silverman@sjhc.london.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Markham Stouffville Hospital</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>L3P 7P3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evridiki Fera, MD</last_name>
      <phone>(416) 617-6864</phone>
      <email>efera@msh.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Diana Monaco</last_name>
      <phone>905-472-7373</phone>
      <phone_ext>6777</phone_ext>
      <email>dmonacom@msh.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Trillium Health Partners -Mississauga Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5B 1B8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Graham, Physician</last_name>
      <phone>416-521-4196</phone>
      <email>Christopher.Graham@thp.ca</email>
    </contact>
    <contact_backup>
      <last_name>Mobina Khurram</last_name>
      <email>Mobina.Khurram@thp.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Trillium Health Partners-Credit Valley Hospital</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Graham, Physician</last_name>
      <phone>416-521-4196</phone>
      <email>Christopher.Graham@thp.ca</email>
    </contact>
    <contact_backup>
      <last_name>Mobina Khurram</last_name>
      <email>Mobina.Khurram@thp.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital - General Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shane English, MD</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>16755</phone_ext>
      <email>senglish@ohri.ca</email>
    </contact>
    <contact_backup>
      <last_name>Irene Watpool</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>78724</phone_ext>
      <email>iwatpool@ohri.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Shane English, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Montfort</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1K 0T2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Chagnon, MD</last_name>
      <phone>613) 746-4621</phone>
      <phone_ext>6051</phone_ext>
      <email>nicolaschagnon@montfort.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Christine-Nadia christinencompas@montfort.on.ca</last_name>
      <phone>613-746-4621</phone>
      <phone_ext>3623</phone_ext>
      <email>christinencompas@montfort.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital - Civic Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shane English, MD</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>16755</phone_ext>
      <email>senglish@ohri.ca</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Porteous</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>17076</phone_ext>
      <email>rporteous@ohri.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Shane English, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queensway Carleton Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K2H 8P4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moira Rushton-Marovac, MD, FRCPC</last_name>
      <phone>613-218-4589</phone>
      <email>mrushtonmarovac@qch.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Laith Bustani</last_name>
      <phone>613-859-7567</phone>
      <email>lbustani@qch.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thunder Bay Regional Health Sciences Centre</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7B 6V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Gregory Gamble, MD</last_name>
      <phone>807-252-3323</phone>
      <email>gambleg@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Lori Moon</last_name>
      <email>moonl@tbh.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>North York General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M2K 1E1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Geagea, MD</last_name>
      <email>anna.geagea@nygh.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Maria Scglag</last_name>
      <email>Maria.Schlag@nygh.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Anna Geagea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Humber River Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M3M 0B2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keren Mandelzweig, MD</last_name>
      <phone>(416) 242-1000</phone>
      <phone_ext>77770</phone_ext>
      <email>kmandelzweig@hrh.ca</email>
    </contact>
    <contact_backup>
      <last_name>Sanjay Manocha, MD</last_name>
      <phone>416-242-1000</phone>
      <phone_ext>77768</phone_ext>
      <email>SManocha@hrh.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Fowler, MD</last_name>
      <phone>647-991-7799</phone>
      <email>rob.fowler@sunnybrook.ca</email>
    </contact>
    <contact_backup>
      <last_name>Asgar Rishu</last_name>
      <phone>647-267-5250</phone>
      <email>Asgar.Rishu@sunnybrook.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Fowler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darrell Tan, MD</last_name>
      <phone>416-864-6060</phone>
      <phone_ext>77505</phone_ext>
      <email>Darrell.tan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Khrystyna Kushniriuk</last_name>
      <phone>416-858-3995</phone>
      <email>Khrystyna.kushniriuk@unityhealth.to</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fralick, MD, PhD</last_name>
      <phone>(647) 403-6187</phone>
      <email>michael.fralick@sinaihealth.ca</email>
    </contact>
    <contact_backup>
      <last_name>Bryan Coburn</last_name>
      <email>bryan.Coburn@uhn.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Coburn, MD</last_name>
      <phone>(416) 634-7457</phone>
      <email>bryan.coburn@uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Maria Kulikova</last_name>
      <phone>6475617621</phone>
      <email>Maria.Kulikova@uhnresearch.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Bryan Coburn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unity Health Toronto - St. Joseph's Health Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6R1B5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Schwartz, MD</last_name>
      <phone>(647) 975-8967</phone>
      <email>kevin.schwartz@unityhealth.to</email>
    </contact>
    <contact_backup>
      <last_name>Kanthi Kavikondala</last_name>
      <phone>416 530 6000</phone>
      <phone_ext>4857</phone_ext>
      <email>kanthi.kavikondala@unityhealth.to</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Université de Montréal (CHUM)</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2X 0A9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madeleine Durand</last_name>
      <phone>(514) 890-8444</phone>
      <email>madeleine.durand.chum@ssss.gouv.qc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Stéphanie Matte</last_name>
      <phone>514-816-8153</phone>
      <email>stephanie.matte.chum@ssss.gouv.qc.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre-Glen Site Royal Victoria Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Cheng, MD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>35064</phone_ext>
      <email>matthew.cheng@mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jonathan Roger, MSc.</last_name>
      <phone>1 438 404 1919</phone>
      <email>jonathan.roger@mail.mcgill.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Cheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Québec - Université Laval</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1J 1Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Turgeon, MD</last_name>
      <phone>(418) 525-4444</phone>
      <phone_ext>66064</phone_ext>
      <email>alexis.turgeon@crchudequebec.ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>David Bellamare</last_name>
      <phone>418-525-4444</phone>
      <phone_ext>66060</phone_ext>
      <email>David.Bellemare@crchudequebec.ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Alexis Turgeon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Québec- Université Laval</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois Lellouche, MD</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>3572</phone_ext>
      <email>francois.lellouche@criucpq.ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Lizotte</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>3937</phone_ext>
      <email>patricia.lizotte@criucpq.ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Francois Lellouche, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois Lamontagne, MD</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>16208</phone_ext>
      <email>francois.lamontagne@usherbrooke.ca</email>
    </contact>
    <contact_backup>
      <last_name>Dominique Marcoux</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>16208</phone_ext>
      <email>dominique.marcoux.ciussse-chus@ssss.gouv.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Francois Lamontagne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2020</study_first_posted>
  <last_update_submitted>September 24, 2020</last_update_submitted>
  <last_update_submitted_qc>September 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lopinavir/ritonavir</keyword>
  <keyword>Hydroxychloroquine</keyword>
  <keyword>Remdesivir</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ritonavir</mesh_term>
    <mesh_term>Lopinavir</mesh_term>
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>As per World Health Organization policies on data sharing in a Public Health Emergency, any clinical trial outcome data will be shared at the earliest possible opportunity. In addition, given the nature of this protocol, being performed across regions, the DSMB may access other regions trials, and possibly recommend alterations in study design based on accumulating data, through a centralized data repository being built under the auspices of the World Health Organization.
Data Sharing for Secondary Research Data from this study may be used for secondary research. All of the individual subject data collected during the trial will be made available after de-identification through expert determination. The SAP and Analytic Code will also be made available. This data will be available immediately following publication, with no end date, as part of data sharing requirements from journals and funding agencies.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Unknown and variable</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

